Christofer Juhlin C, Mete O, Baloch ZW The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer 30, 2023.

Baloch ZW, Asa SL, Barletta JAet al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33: 27-63, 2022.

Hedinger C WE, Sobin LH: WHO. Histologic Typing of Thyroid Tumors, New York: Springer-Verlag, 1988.

DeLellis RA, Lloyd RD, Heitz PU, Eng C, eds.: WHO: Pathology and Genetics. Tumours of Endocrine Organs., Lyon, France: IARC Press, 2004, Pages.

WHO Classification of Tumours of Endocrine Organs, Lyon, France: WHO/IARC Press, 2017.

Baloch Z, LiVolsi VA The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look-backs to look-ahead. Diagn Cytopathol, 2020.

The Bethesda System for Reporting Thyroid Cytopathology. Definitions, Criteria, and Explanatory Notes., Switzerland, 2018.

Rosario PW, de Castro Nicolau T The value of ultrasonography for the indication of fine-needle aspiration in autonomous thyroid nodules. Diagn Cytopathol 49: 363-366, 2021.

Mistry R, Hillyar C, Nibber A, Sooriyamoorthy T, Kumar N Ultrasound Classification of Thyroid Nodules: A Systematic Review. Cureus 12: e7239, 2020.

Garber JR, Papini E, Frasoldati A et al. American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool. Endocr Metab Immune Disord Drug Targets 21: 2104-2115, 2021.

Grani G, Sponziello M, Pecce V, Ramundo V, Durante C Contemporary Thyroid Nodule Evaluation and Management. J Clin Endocrinol Metab 105, 2020.

Kim PH, Suh CH, Baek JH, Chung SR, Choi YJ, Lee JH Unnecessary thyroid nodule biopsy rates under four ultrasound risk stratification systems: a systematic review and meta-analysis. Eur Radiol 31: 2877-2885, 2021.

Maxwell C, Sipos J Clinical diagnostic evaluation of thyroid nodules. Endocrinol Metab Clin North Am 48: 61-84, 2019.

Wang Z, Vyas CM, Van Benschoten Oet al. Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients >/=70 Years Old. Thyroid 28: 465-471, 2018.

Cordes M, Schmidkonz C, Horstrup K, Weppler M, Kuwert T Fine-needle aspiration biopsies of thyroid nodules. Nuklearmedizin 57: 211-215, 2018.

Anand B, Ramdas A, Ambroise MM, Kumar NP The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study. J Thyroid Res 2020: 8095378, 2020.

Vuong HG, Ngo HTT, Bychkov Aet al. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis. Cancer Cytopathol 128: 238-249, 2020.

Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol 15: 84–89, 1996.

Cibas ES, Ali SZ The bethesda system for reporting thyroid cytopathology. THYROID 19: 1159-1165, 2009.

Ali SZ, Cibas ES The bethesda system for reporting thyroid cytopathology : definitions, criteria, and explanatory notes, 2018.

Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS The Diagnosis and Management of Thyroid Nodules: A Review. JAMA 319: 914-924, 2018.

Nguyen TPX, Truong VT, Kakudo K, Vuong HG The diversities in thyroid cytopathology practices among Asian countries using the Bethesda system for reporting thyroid cytopathology. Gland Surg 9: 1735-1746, 2020.

Park VY, Lee HS, Kim EK, Kwak JY, Yoon JH, Moon HJ Frequencies and malignancy rates of 6-tiered Bethesda categories of thyroid nodules according to ultrasound assessment and nodule size. Head Neck 40: 1947-1954, 2018.

Chakravarthy NS, Chandramohan A, Prabhu AJet al. Ultrasound-guided Fine-needle Aspiration Cytology along with Clinical and Radiological Features in Predicting Thyroid Malignancy in Nodules >/=1 cm. Indian J Endocrinol Metab 22: 597-604, 2018.

Hirokawa M, Suzuki A, Higuchi Met al. The Japanese reporting system for thyroid aspiration cytology 2019 (JRSTAC2019). Gland Surg 9: 1653-1662, 2020.

Trimboli P, Crescenzi A, Castellana M, Giorgino F, Giovanella L, Bongiovanni M Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis. Endocrine 63: 430-438, 2019.

Cross PA, Poller D The Bethesda thyroid terminology and progress towards international agreement on thyroid FNA cytology reporting. Cytopathology 21: 71-74, 2010.

Poller DN, Bongiovanni M, Trimboli P Risk of malignancy in the various categories of the UK Royal College of Pathologists Thy terminology for thyroid FNA cytology: A systematic review and meta-analysis. Cancer Cytopathol 128: 36-42, 2020.

Pusztaszeri M, Rossi ED, Auger Met al. The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel. Acta Cytol 60: 399–405, 2016.

Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis. Acta Cytol 56: 333-339, 2012.

Nylen C, Mechera R, Marechal-Ross Iet al. Molecular Markers Guiding Thyroid Cancer Management. Cancers (Basel) 12, 2020.

Nishino M, Nikiforova M Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules. Arch Pathol Lab Med 142: 446-457, 2018.

Bizzarro T, Martini M, Capodimonti Set al. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification. Cancer 124: 699-710, 2016.

Carty SE, Ohori NP, Hilko DAet al. The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules). Ann Surg 272: 621-627, 2020.

Sheffield BS, Masoudi H, Walker B, Wiseman SM Preoperative diagnosis of thyroid nodules using the Bethesda System for Reporting Thyroid Cytopathology: a comprehensive review and meta-analysis. Expert Rev Endocrinol Metab 9: 97-110, 2014.

Brown C, Mangano W, Thompson S, Richmond B Factors Predicting Thyroid Malignancy in Fine Needle Aspiration Biopsy Specimens Classified as Atypia of Uncertain Significance/Follicular Lesion of Uncertain Significance. Am Surg 84: 1207-1213, 2018.

Mosca L, Silva L, Carneiro PCet al. Malignancy rates for Bethesda III subcategories in thyroid fine needle aspiration biopsy (FNAB). Clinics (Sao Paulo) 73: e370, 2018.

Valderrabano P, Khazai L, Thompson ZJet al. Cancer risk stratification of indeterminate thyroid nodules: A cytological approach. THYROID, 2017.

Renshaw AA Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol 116: 477–482., 2001.

Faquin WC The thyroid gland: recurring problems in histologic and cytologic evaluation. Arch Pathol Lab Med 132: 622-632, 2008.

VandenBussche CJ, Baloch ZW The cytologic diagnosis of "atypical": Criteria and controversies. Diagn Cytopathol 50: 143-145, 2022.

Poller DN, Megadmi H, Ward MJA, Trimboli P Hurthle Cells on Fine-Needle Aspiration Cytology Are Important for Risk Assessment of Focally PET/CT FDG Avid Thyroid Nodules. Cancers (Basel) 12, 2020.

Sengul D, Sengul I, Van Slycke S Risk stratification of the thyroid nodule with Bethesda indeterminate cytology, category III, IV, V on the one surgeon-performed US-guided fine-needle aspiration with 27-gauge needle, verified by histopathology of thyroidectomy: the additional value of one surgeon-performed elastography. Acta Chir Belg: 1–9, 2019.

Granel-Villach L, Fortea-Sanchis C, Laguna-Sastre JM, Escrig-Sos J Performance of the Bethesda system in the citopathological diagnosis of the thyroid nodule. Cirugia espanola 96: 599-600, 2018.

Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Grebe SK Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab 88: 3284-3291, 2003.

Landau MS, Nikiforov YE, Ohori NP, Chiosea SI Impact of molecular testing on detecting mimics of oncocytic neoplasms in thyroid fine-needle aspirates diagnosed as follicular neoplasm of Hurthle cell (oncocytic) type. Cancer Cytopathol, 2021.

Ohori NP Molecular testing and thyroid nodule management in North America. Gland Surg 9: 1628–1638, 2020.

Khayyata S, Barroeta JE, LiVolsi VA, Baloch ZW Papillary hyperplastic nodule: pitfall in the cytopathologic diagnosis of papillary thyroid carcinoma. Endocr Pract 14: 863-868, 2008.

Albores-Saavedra J, Wu J The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol 17: 1-18, 2006.

Khurana KK, Baloch ZW, LiVolsi VA Aspiration cytology of pediatric solitary papillary hyperplastic thyroid nodule. Arch Pathol Lab Med 125: 1575-1578., 2001.

Guan H, Matonis D, Toraldo G, Lee SL Clinical Significance of Thyroid-Stimulating Hormone Receptor Gene Mutations and/or Sodium-Iodine Symporter Gene Overexpression in Indeterminate Thyroid Fine Needle Biopsies. Frontiers in endocrinology 9: 566, 2018.

LiVolsi VA, Baloch Z Noninvasive Follicular Tumor With Papillary-like Nuclear Features: A Practice Changer in Thyroid Pathology. Arch Pathol Lab Med, 2020.

Rossi ED, Faquin WC, Baloch Zet al. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Update and Diagnostic Considerations-a Review. Endocr Pathol 30: 155-162, 2019.

Zhou H, Baloch ZW, Nayar Ret al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Cancer Cytopathol 126: 20-26, 2018.

Macerola E, Poma AM, Vignali Pet al. Molecular Genetics of Follicular-Derived Thyroid Cancer. Cancers (Basel) 13, 2021.

Basolo F, Macerola E, Ugolini C, Poller DN, Baloch Z The Molecular Landscape of Noninvasive Follicular Thyroid Neoplasm With Papillary-like Nuclear Features (NIFTP): A Literature Review. Adv Anat Pathol 24: 252-258, 2017.

Nikiforova MN, Nikiforov YE, Ohori NP GLIS rearrangements in thyroid nodules: A key to preoperative diagnosis of hyalinizing trabecular tumor. Cancer Cytopathol 127: 560-566, 2019.

Bishop JA, Ali SZ Hyalinizing trabecular adenoma of the thyroid gland. Diagn Cytopathol 39: 306-310, 2011.

Agarwal S, Mathur SR, Ray R, Sharma SC, Sinha P Cytopathological diagnosis of hyalinizing trabecular tumour, a rare thyroid neoplasm. Cytopathology 21: 133-134, 2010.

Gupta S, Modi S, Gupta V, Marwah N Hyalinizing trabecular tumor of the thyroid gland. J Cytol 27: 63-65, 2010.

Baloch ZW, LiVolsi VA Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol 125 Suppl: S135–144, 2006.

Nikiforova MN, Nikitski AV, Panebianco Fet al. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland. Thyroid 29: 161-173, 2019.

Bongiovanni M, Sadow PM, Faquin WC Poorly differentiated thyroid carcinoma: a cytologic-histologic review. Adv Anat Pathol 16: 283-289, 2009.

Bongiovanni M, Bloom L, Krane JFet al. Cytomorphologic features of poorly differentiated thyroid carcinoma: a multi-institutional analysis of 40 cases. Cancer Cytopathol 117: 185-194, 2009.

Xu B, Fuchs T, Dogan Set al. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases. THYROID 30: 1505-1517, 2020.

Deeken-Draisey A, Yang GY, Gao J, Alexiev BA Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol 82: 140-148, 2018.

Pusztaszeri MP, Bongiovanni M, Brimo F Do we need PD-L1 as a biomarker for thyroid cytologic and histologic specimens? Cancer Cytopathol 128: 160-165, 2020.

Hurthle K Beitrage zur kenntnis des sekretionsvorganges in der schilddruse. Arch FD Ges Physiol 56: 1, 1894.

Nikiforova MN, Lepe M, Tolino LAet al. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing. Cancer Cytopathol, 2020.

Kumar N, Gupta R, Gupta S Molecular testing in diagnosis of indeterminate thyroid cytology: Trends and drivers. Diagn Cytopathol 48: 1144-1151, 2020.

Ngo HTT, Nguyen TPX, Vu THet al. Impact of Molecular Testing on the Management of Indeterminate Thyroid Nodules Among Western and Asian Countries: a Systematic Review and Meta-analysis. Endocr Pathol, 2020.

Ohori NP, Landau MS, Manroa P, Schoedel KE, Seethala RR Molecular-derived estimation of risk of malignancy for indeterminate thyroid cytology diagnoses. J Am Soc Cytopathol 9: 213-220, 2020.

Spaulding SL, Ho R, Everest S, Chai RL The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature. Am J Otolaryngol 41: 102312, 2020.

Rossi ED, Raffaelli M, Minimo Cet al. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies. Cancer 105: 87-95, 2005.

Rossi ED, Raffaelli M, Mule Aet al. Relevance of Immunocytochemistry on Thin-layer Cytology in Thyroid Lesions Suspicious for Medullary Carcinoma: A Case-control Study. Appl Immunohistochem Mol Morphol, 2008.

Papathomas TG, Nose V New and Emerging Biomarkers in Endocrine Pathology. Adv Anat Pathol 26: 198-209, 2019.

Dvorak K, Higgins A, Palting J, Cohen M, Brunhoeber P Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review. Pathol Oncol Res 25: 349-359, 2019.

Baloch Z, Mete O, Asa SL Immunohistochemical Biomarkers in Thyroid Pathology. Endocr Pathol 29: 91-112, 2018.

Straccia P, Brunelli C, Rossi EDet al. The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology. Cytopathology 30: 460-467, 2019.

Smith AL, Williams MD, Stewart Jet al. Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma. Cancer Cytopathol 126: 406–413, 2018.

Lee SR, Yim H, Han JHet al. VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases. Am J Clin Pathol 143: 437-444, 2015.

Alzumaili B, Xu B, Spanheimer PMet al. Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome. Mod Pathol 33: 1690-1701, 2020.

Liu CY, Bychkov A, Agarwal Set al. Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region. Diagn Cytopathol 49: 60-69, 2021.

Baloch ZW, LiVolsi VA Special types of thyroid carcinoma. Histopathology 72: 40-52, 2018.

Solomon AC, Baloch ZW, Salhany KE, Mandel S, Weber RS, LiVolsi VA Thyroid Sclerosing Mucoepidermoid Carcinoma With Eosinophilia: Mimic of Hodgkin Disease in Nodal Metastases. Arch Pathol Lab Med 124: 446-449, 2000.

Baloch ZW, Solomon AC, LiVolsi VA Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol 13: 802-807., 2000.

Erickson LA Unique Clinical Significance of the Cribriform-Morular Variant of Papillary Thyroid Carcinoma. Mayo Clin Proc 95: 831–833, 2020.

Sakurai K, Onouchi T, Yamada Set al. Cytohistology of morule in cribriform-morular variant of papillary thyroid carcinoma. Malays J Pathol 41: 339-343, 2019.

Ali SZ, Cibas ES: The Bethesda System for Reporting Thyroid Cytopathology Definitions, Criteria and Explanatory Notes, Boston, MA: Springer US, 2010.

Ali SZ Thyroid cytopathology: Bethesda and beyond. Acta Cytol 55: 4-12, 2011.

Bongiovanni M, Faquin WC, Giovanella L, Durante C, Kopp P, Trimboli P Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspected malignancy or malignant fine-needle aspiration cytology findings: a systematic review and meta-analysis. Eur J Endocrinol 181: 389-396, 2019.

Haaga E, Kalfert D, Ludvikova M, Kholova I Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Is Not a Cytological Diagnosis, but It Influences Cytological Diagnosis Outcomes: A Systematic Review and Meta-Analysis. Acta Cytol 66: 85-105, 2022.

Krauss EA, Mahon M, Fede JM, Zhang L Application of the Bethesda Classification for Thyroid Fine-Needle Aspiration: Institutional Experience and Meta-analysis. Arch Pathol Lab Med 140: 1121-1131, 2016.